ZS7-58558-14273
4 vaccinations
2 coded responses
29 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 620 / IL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
- 2020-12-29
- 2020-12-30
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-18
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Urticaria — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: HivesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Swelling face, Urticaria — Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Urticaria; hives; facial swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-11
- 2021-02-18
- 2021-02-23
- 2021-04-05
- 2021-04-22
- 2021-07-20
-
2021-12-10
Dose 3 — Moderna
- 2022-01-19
-
2022-12-05
Dose 4 — Moderna
-
2022-12-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-12-08
- 2022-12-10
- 2022-12-11
- 2022-12-12
- 2022-12-21
- 2022-12-28
- 2023-01-11
- 2023-01-18
- 2023-03-06
- 2023-06-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Moderna | No |
| 4 | 2022-12-05 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-24 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Hives
Systemic reaction (other): Urticaria; hives; facial swelling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Swelling face | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release